In this edition:
CheckMate 214: circulating KIM-1 in advanced RCC
KEYMAKER-U03 substudy 03B: second-line lenvatinib + belzutifan in advanced RCC
COTRIMS: final results of RPLND in stage IIA/B seminoma
NIAGARA: EFS/OS outcomes & pCR
RC48-C017: perioperative disitamab vedotin + toripalimab in HER2-expressing MIBC
ARPIs in metastatic hormone-sensitive prostate cancer
TALAPRO-2: final OS & rPFS results
Radical prostatectomy vs. radiotherapy in high-risk prostate cancer
A predictive biomarker of response to radiotherapy dose escalation in prostate cancer
ENZA-p: updated OS & health-related QoL
Please login below to download this issue (PDF)